Experimental immune cell therapy for leukemia shows promise but trial halted early
NCT ID NCT04511130
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 21 times
Summary
This study tested a special type of immune cell (MT-401) made from a donor's blood to treat acute myeloid leukemia (AML) after a stem cell transplant. The cells were designed to attack cancer cells while leaving healthy tissue alone. The trial aimed to see if this approach could prevent relapse or treat leukemia that returned after transplant. However, the study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
City of Hope National Medical Center
Duarte, California, 91010, United States
-
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, 44195, United States
-
John Theurer Cancer Center at Hackensack UMC
Hackensack, New Jersey, 07601, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic Cancer Center-Rochester
Rochester, Minnesota, 55905, United States
-
Mayo Clinical Cancer Center-Florida
Jacksonville, Florida, 32224, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
Moores Cancer Center at University of Californa San Diego
La Jolla, California, 92093, United States
-
UCLA Department of Medicine
Los Angeles, California, 90095, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
-
University of Chicago
Chicago, Illinois, 77027, United States
-
University of Iowa Hospitals & Clinics
Iowa City, Iowa, 52242, United States
-
Weill Cornell Medicine | NewYork-Presbyterian
New York, New York, 10027, United States
-
Winship Cancer Institute of Emory University
Atlanta, Georgia, 303222, United States
-
Yale Cancer Center
New Haven, Connecticut, 06519, United States
Conditions
Explore the condition pages connected to this study.